GE Healthcare licenses lung imaging technology to Merck
NEW YORK—GE Healthcare Monday said it inked an agreement with drug maker Merck & Co. to provide lung imaging technology to assist in respiratory drug development.
Under the deal, Merck will receive non-exclusive access to GE's Spin Signal Technology, which provides quick MRIs of lung function.
Chalfont St. Giles, England-based GE Healthcare, a division of the General Electric Co., did not provide financial details of the agreement.
Shares of GE fell 10 cents to $33.24 in midday trading, while shares of Whitehouse Station, N.J.-based Merck traded up 3 cents to $39.40.
© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
